Vossen, R.

patient mutation cancer breast response tumor breast cancer tamoxifen treatment tp 53 level status protein tp 53 mutation chemotherapy therapy tamoxifen treatment study analysis factor adjuvant tp 53 gene month disease value breast cancer patients survival tp 53 mutations tamoxifen therapy expression tp 53 status table multivariate wild-type tp 53 breast tumors growth factor first-line tissue wild-type relapse multivariate analysis vegf status adjuvant therapy result adjuvant chemotherapy tumor characteristics disease-free interval contact dna p 53 expression receptor growth estrogen vegf levels range metastatic sequencing sample relationship subset fmol /mg protein chemo interval prognostic base model tp 53 genotype analyses ratio prognostic value resistance model progression contact er-positive 1998. vegf production menopausal status stage rotterdam amersham pharmacia 1995.